Graft-versus-leukemia in chronic lymphocytic leukemiaBEN-BASSAT, I; RAANANI, P; GALE, R. P et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 8, pp 441-446, issn 0268-3369, 6 p.Article

GVL effect in plasmacytoid DC leukemia/lymphomaKALOYANNIDIS, P; ZOMAS, A; PATERAKIS, G et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 5, pp 961-962, issn 0268-3369, 2 p.Article

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantationRIDDELL, Stanley R; BERGER, Carolina; MURATA, Makoto et al.Blood reviews. 2003, Vol 17, Num 3, pp 153-162, issn 0268-960X, 10 p.Article

Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia? Authors' replyCHUNDURI, S; DOBOGAI, L. C; BRUNO, A et al.Leukemia. 2005, Vol 19, Num 3, pp 456-457, issn 0887-6924, 2 p.Article

Stem cell transplantation-harnessing of graft-versus-malignancyANTIN, Joseph H.Current opinion in hematology. 2003, Vol 10, Num 6, pp 440-444, issn 1065-6251, 5 p.Article

Graft-versus-leukemia effects of transplantation and donor lymphocytesKOLB, Hans-Jochem.Blood. 2008, Vol 112, Num 12, pp 4371-4383, issn 0006-4971, 13 p.Article

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantationKOLB, H.-J.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 321-329, issn 0042-9007, SUP2Conference Paper

Perspectives d'immunothérapie des hémopathies malignes = New strategies in immunotherapy for hematologic malignanciesBUZYN, A; OSTANKOVITCH, M; KEMULA, M et al.Hématologie (Montrouge). 1997, Vol 3, Num 6, pp 518-527, issn 1264-7527Article

Type I-IFNs control GVHD and GVL responses after transplantationROBS, Renee J; KREIJVELD, Ellen; MARKEY, Kate A et al.Blood. 2011, Vol 118, Num 12, pp 3399-3409, issn 0006-4971, 11 p.Article

Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cellsMEGURO, A; OZAKI, K; NAKAE, S et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 12, pp 1557-1565, issn 0268-3369, 9 p.Article

Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte InfusionWANDI ZHANG; CHOI, Jaewon; RITZ, Jerome et al.Clinical cancer research (Print). 2010, Vol 16, Num 10, pp 2729-2739, issn 1078-0432, 11 p.Article

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationVAGO, Luca; FORNO, Barbara; MIDDLETON, Derek et al.Blood. 2008, Vol 112, Num 8, pp 3488-3499, issn 0006-4971, 12 p.Article

Cytokines in Graft-Versus-Host disease and the graft-versus-leukemia reactionDEEG, H. Joachim.International journal of hematology. 2001, Vol 74, Num 1, pp 26-32, issn 0925-5710Article

High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantationLEE, K.-H; LEE, J.-H; KIM, S et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 2, pp 147-152, issn 0268-3369Article

Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporineRINGDEN, O; LABOPIN, M; GORIN, N. C et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 733-734, issn 0041-1345Conference Paper

Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitutionNING LI; MATTE-MARTONE, Catherine; SHLOMCHIK, Warren D et al.Blood. 2011, Vol 118, Num 22, pp 5965-5976, issn 0006-4971, 12 p.Article

Soluble lymphotoxin is an important effector molecule in GVHD and GVLMARKEY, Kate A; BURMAN, Angela C; WILSON, Yana A et al.Blood. 2010, Vol 115, Num 1, pp 122-132, issn 0006-4971, 11 p.Article

In pursuit of the allo-immune response in multiple myeloma : where do we go from here?COOK, G; BIRD, J. M; MARKS, D. I et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 2, pp 91-99, issn 0268-3369, 9 p.Article

Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemiaSTORB, R.Leukemia. 2002, Vol 16, Num 4, pp 753-754, issn 0887-6924Article

Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation : demonstration of a graft-versus-myelofibrosis effectCERVANTES, F; ROVIRA, M; URBANO-ISPIZUA, A et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 6, pp 697-699, issn 0268-3369Article

Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusionSTEIN, M; FELDMAN, E; SEITER, K et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 10, pp 1073-1077, issn 0268-3369Article

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus : A distinct entity?LEBLOND, V; DAVI, F; CHARLOTTE, F et al.Journal of clinical oncology. 1998, Vol 16, Num 6, pp 2052-2059, issn 0732-183XArticle

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapyGIRALT, S; ESTEY, E; CLAXTON, D et al.Blood. 1997, Vol 89, Num 12, pp 4531-4536, issn 0006-4971Article

Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-LeukemiaVAGO, Luca; TOFFALORI, Cristina; CICERI, Fabio et al.Seminars in oncology. 2012, Vol 39, Num 6, pp 707-715, issn 0093-7754, 9 p.Article

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantationALPDOGAN, Onder; ENG, Jeffrey M; MURIGLAN, Stephanie J et al.Blood. 2005, Vol 105, Num 2, pp 865-873, issn 0006-4971, 9 p.Article